With production value of USD1.7 billion, Saudi Arabia accounts for 7.9% of the Middle East and North Africa total in 2023. The industry’s exports share increases in 2023 to 21.5% of total production output. The industry’s profitability increases and stands at 44.3% of production value in 2023, the second highest regionally. The costs of the industry decrease by 4.2% in 2023, largely driven by declining B2B costs. The total number of companies decreases in 2023, to 119 units. The industry is fragmented, with the top five companies generating 42.7% of total production value in 2023. Tabuk Pharmaceutical Mfg Co is the largest company in Saudi Arabia, generating 22.1% of the industry’s total production value in 2023. Saudi Arabia has the largest market size for pharmaceuticals regionally, with demand reaching USD9.9 billion in 2023. Households drive market demand, with household spending representing 62.4% of total demand in 2023. The market is dominated by foreign suppliers, as imports account for 85.0% of total market size in 2023.
Delivery:
Files are delivered directly into your account soon after payment is received and any tax is certification is verified (where applicable).
This report comes in PDF.
This Euromonitor industrial report provides unique information on Pharmaceuticals in Saudi Arabia: ISIC 2423. With this industrial report, you’ll be able to explore the industry from its sources of supply to its buyers. The Pharmaceuticals in Saudi Arabia: ISIC 2423 report includes: Industry datagraphics including production data, exports, imports, cost structure, and profitability
Pharmaceuticals and Medical Equipment is an aggregation of Pharmaceuticals, Medical and Surgical Equipment.
See All of Our DefinitionsIf you purchase a report that is updated in the next 60 days, we will send you the new edition and data extraction Free!